Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant adeno-associated viruses for delivering gene editing molecules to embryonic cells

Recombinant adeno-associated viruses for delivering gene editing molecules to embryonic cells

US Patent 11882815 · Granted Jan 30, 2024

Estimated economic value: $1,530,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

AAV-mediated gene therapy for maple syrup urine disease (MSUD)2025
Minigene therapy2025
Modified AAV constructs and uses thereof2025
Viral vector production2025
Gene therapeutics for treating bone disorders2025
Adeno-associated virus gene therapy for 21-hydroxylase deficiency2025
Modified AAV constructs and uses thereof2024
Use of inverted terminal repeats (ITRS) from adeno-associated virus serotypes 8 2024
Compositions and methods for transient delivery of nucleases2024
Anti-angiogenic miRNA therapeutics for inhibiting corneal neovascularization2023
AAV's and uses thereof2023
Isolation of novel AAV's and uses thereof2023